Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.
Choose from the criteria below to find an activity that fits you best.
The Antimicrobial Stewardship Certificate Program (ASP) is an innovative and intensive practice-based activity for pharmacists focusing on the pharmacist's role in the area of appropriate use of antimicrobial agents. The certificate program, which emphasizes a health care team approach, seeks to foster the development of a strong knowledgebase in microbiology, pharmacology and disease state management in order to successfully implement an antibiotic stewardship program that will improve patient care, reduce healthcare expenditures and potentially reduce rates of resistance and prolong the longevity of the limited number of antimicrobial agents available to treat infections.
The program goals/learning objectives are the following:
The Antimicrobial Stewardship certificate training program is ACPE accredited and conducted in three parts:
A Certificate of Achievement will be awarded to participants who successfully complete
all three program components. Participants who successfully complete the program will
be eligible for a 1 year free associate membership in SIDP.
The self-study and webinars must be completed within 8 months and the final project completed within 12 months of registration. To sign up and access the program, use the Pay with a Credit Card or Pay with a Check links listed at the top of the page.
Participant cost is $750 per pharmacist. This amount includes the home study section,
four to six live webinars, and the skills development/implementation component at
your practice site. Click on "Pay with a Credit Card" or "Pay with a Check"
above to purchase and enroll in the program. If you wish to participate in only a
portion of the program, Phase 1 is available for $500 per pharmacist. Click
here to purchase Phase 1 only. Phases 1 and 2 are available for $688 per
pharmacist. Click here
to purchase Phases 1 & 2 only.
For institutions or healthcare facilities with payment from the same institution, we provide the following discounts:
6-10 healthcare professionals - 5% discount
11-15 healthcare professionals - 10% discount
>15 healthcare professionals - 15% discount
To receive discounted pricing, click here to complete the purchase.
For trainees (e.g., residents, fellows, and graduate students) the cost is $550 per individual for the full program. To receive a discount or for questions about them, please contact ProCE at email@example.com. To receive discounted pricing, click here to complete the purchase.
For complete details on the program, please see our downloadable Announcement.
Initial Release Date: 1-15-2018
Expiration Date: 1-15-2021
Practice Activity Number: 0221-9999-18-004-B01-P
This CE activity is jointly provided by ProCE, Inc. and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Practice Activity Number 0221-9999-18-004-B01-P has been assigned to this practice-based CE activity (initial release date 1-15-18). This CE activity is approved for 40.0 contact hours (0.4 CEUs) in states that recognize ACPE providers. The participant can elect to complete three additional webinars at no additional cost and earn 44.5 contact hours (4.45 CEUs). Statements of completion will be issued online as individual modules are completed with a post-test score of 80% or higher and completion of an online evaluation. UANs for the individual activity modules are listed in the Activity Announcement.
No commercial funding. This activity is self-funded by SIDP and registration fees.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.